AstraZeneca And Shionogi Launch Arteriosclerosis Awareness Campaign In Japan
This article was originally published in PharmAsia News
Executive Summary
AstraZeneca and Shionogi will jointly launch a public relations campaign to raise awareness for arteriosclerosis in Japan. The two established a Web site July 21. The companies aim to educate on the lack of self noticeable symptoms of the disease and urge more people to have a medical checkup. (Click here for more - Japanese language
You may also be interested in...
ANDA Submissions Drop To Start FY2021
First quarter submission volume is the second lowest of the GDUFA era, in part because of BE study problems caused by the pandemic.
QUOTED. 22 January 2021. Neil Moat.
The Centers for Medicare and Medicaid Services has agreed to provide national Medicare coverage for mitral valve transcatheter edge-to-edge repair under a new coverage with evidence development policy. See what Neil Moat, chief medical officer for Abbott’s structural heart business, said about it here.
ICCR’s Growing Membership Ensures Diverse Cosmetics Regulatory Perspectives – PCPC
South Korea’s Ministry of Food and Drug Safety and Taiwan’s Food and Drug Administration will transition from ICCR observers to full members, joining regulatory authorities from the US, Europe, Japan, Canada and Brazil. PCPC’s Francine Lamoriello, EVP of global affairs, discusses.
Need a specific report? 1000+ reports available
Buy Reports